Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Immedica Pharma AB

Closing information (x1000 EUR)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 81,600 Less Arrow 54,778 Less Arrow 48,399
Financial expenses 6,424 More Arrow 6,935 Less Arrow 4,189
Earnings before taxes 7,532 Less Arrow 2,930 More Arrow 5,463
EBITDA 20,994 Less Arrow 16,787 More Arrow 20,352
Total assets 200,600 Less Arrow 138,205 Less Arrow 118,129
Current assets 52,894 Less Arrow 31,041 Less Arrow 30,786
Current liabilities 30,258 Less Arrow 15,229 Less Arrow 11,160
Equity capital 74,816 Less Arrow 59,241 Less Arrow 45,355
- share capital 5 Less Arrow 4 More Arrow 5
Employees (average) 88 Less Arrow 69 Less Arrow 52

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 37.3% More Arrow 42.9% Less Arrow 38.4%
Turnover per employee 927 Less Arrow 794 More Arrow 931
Profit as a percentage of turnover 9.2% Less Arrow 5.3% More Arrow 11.3%
Return on assets (ROA) 7.0% More Arrow 7.1% More Arrow 8.2%
Current ratio 174.8% More Arrow 203.8% More Arrow 275.9%
Return on equity (ROE) 10.1% Less Arrow 4.9% More Arrow 12.0%
Change turnover 26,663 Less Arrow 10,299 Less Arrow 7,530
Change turnover % 49% Less Arrow 23% Less Arrow 18%
Chg. No. of employees 19 Less Arrow 17 Less Arrow 8
Chg. No. of employees % 28% More Arrow 33% Less Arrow 18%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.